(Q44188616)

30 November 2017

title

Melatonin response to atenolol administration in depression: indication of beta-adrenoceptor dysfunction in a subtype of depression (English)

1 reference

30 November 2017

0 references

Paparrigopoulos T

1

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 December 2002

1 reference

Acta Psychiatrica Scandinavica

30 November 2017

published in

1 reference

30 November 2017

volume

106

1 reference

30 November 2017

issue

6

1 reference

30 November 2017

page(s)

440-445

1 reference

30 November 2017

cites work

Melatonin and psychiatry

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Melatonin biosynthesis in the mammalian pineal gland

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Atenolol reduces plasma melatonin concentration in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Atenolol in premenstrual syndrome: a test of the melatonin hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

The effect of atenolol, a beta1-adrenergic antagonist, on nocturnal plasma melatonin secretion: evidence for a dose-response relationship in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

A New Depression Scale Designed to be Sensitive to Change

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Prediction of nocturnal plasma melatonin from morning urinary measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Low and high melatonin excretors among healthy individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Serum melatonin in relation to clinical variables in patients with major depressive disorder and a hypothesis of a low melatonin syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Nocturnal melatonin and cortisol secretion in newly admitted psychiatric inpatients. Implications for affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

The relationship between the pineal gland and the pituitary-adrenal axis in health, endocrine and psychiatric conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Preliminary observations on the suppression of nocturnal plasma melatonin levels by short-term administration of diazepam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Effect of Adrenergic Stimulation and Blockade on Melatonin Secretion in the Human

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Nocturnal Elevation of Plasma Melatonin and Urinary 5-Hydroxyindoleacetic Acid in Young Men: Attempts at Modification by Brief Changes in Environmental Lighting and Sleep and by Autonomic Drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Atenolol in seasonal affective disorder: a test of the melatonin hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Differences in nocturnal melatonin secretion between melancholic depressed patients and control subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Suppression of plasma melatonin by a single dose of the benzodiazepine alprazolam in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

The psychopharmacology of the human pineal

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Effect of propranolol on serum-melatonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Normative melatonin excretion: a multinational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

A simplified radioimmunoassay for melatonin and its application to biological fluids. Preliminary observations on the half-life of plasma melatonin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Melatonin in serum and urine in patients with idiopathic pain syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Neuroendocrine aspects of primary endogenous depression. XI. Serum melatonin measures in patients and matched control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

A comparison of melatonin secretion in depressed patients and normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Treatment of a patient with seasonal premenstrual syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

Depressed melatonin secretion in patients with nightmares due to beta-adrenoceptor blocking drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0447.2002.02342.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1034/J.1600-0447.2002.02342.X

1 reference

30 November 2017

1 reference